<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01332838</url>
  </required_header>
  <id_info>
    <org_study_id>COSSCA</org_study_id>
    <nct_id>NCT01332838</nct_id>
  </id_info>
  <brief_title>A Comparison of Specialized Versus Standard Compression After Saphenous Ablation</brief_title>
  <official_title>A Comparison of Specialized Versus Standard Compression After Saphenous Ablation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Washington</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Lake Washington Vascular Associates</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Sigvaris, Inc</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Washington</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine if the use of specialized compression garments, in
      comparison to standard compression, improves early patient outcomes after endovenous
      ablation.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>May 2011</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Anticipated">June 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Behavioral Recovery After Varicose Veins (BRAVV) score.</measure>
    <time_frame>7 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Additional scoring and venous duplex ultrasonography</measure>
    <time_frame>7 and 28 days</time_frame>
    <description>Behavioral Recovery After Varicose Veins (BRAVV) score at 28 days, Pain score at 7 and 28 days, Bruising score at 7 and 28 days, Venous Clinical Severity Score (VCSS) at 7 and 28 days, venous duplex ultrasonography at 28 days</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Varicose Veins</condition>
  <arm_group>
    <arm_group_label>Sigvaris special compression stocking</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Standard Compression</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Compression stockings</intervention_name>
    <description>standard 30to 40 mm Hg thigh high compression stockings</description>
    <arm_group_label>Standard Compression</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>compression stockings (Sigvaris )</intervention_name>
    <description>Specialized monoleg compression</description>
    <arm_group_label>Sigvaris special compression stocking</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 years and above

          -  CEAP Class C2 or C3 disease

          -  Incompetence of the great saphenous vein defined a reflux persisting&gt;0.5 seconds in
             the upright position

          -  Planned endovenous ablation of the great saphenous vein

        Exclusion Criteria:

          -  Inability of patient or legal guardian to provide informed consent

          -  Previous history of DVT

          -  Clinical evidence of significant chronic venous disease (CEAP classes C4, C5, C6)

          -  Planned concomitant phlebectomy or sclerotherapy within 4 weeks of endovenous ablation

          -  Documented allergy or intolerance to compression stockings

          -  Arterial insufficiency as documented by an ankle-brachial index &lt;0.5

          -  Known prothrombotic condition

          -  Life expectancy less than 1 year

          -  Inability to return for follow-up due to geographic inaccessibility, concurrent
             medical conditions or substance abuse

          -  Weight greater than 220 pounds or height &gt; 6'4&quot;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Linda S Harrison</last_name>
    <phone>206-221-3341</phone>
    <email>lsh3@uw.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mark H Meissner, MD</last_name>
    <email>meissner@uw.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Washington</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Mark H Meissner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 30, 2011</study_first_submitted>
  <study_first_submitted_qc>April 8, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2011</study_first_posted>
  <last_update_submitted>April 29, 2011</last_update_submitted>
  <last_update_submitted_qc>April 29, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Mark Meissner, MD</name_title>
    <organization>University of Washington</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Varicose Veins</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 24, 2016</submitted>
    <returned>December 15, 2016</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

